Kazuki Yatsuzuka, Jun Muto, Masamoto Murakami. Comments about the comparative bulk RNA sequencing between palmoplantar pustulosis and dyshidrotic palmoplantar eczema. F1000Research. 2024. 13. 1494-1494
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui. Authors’ Reply to Wang et al., “Comment on ‘Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial’”. American Journal of Clinical Dermatology. 2024
Xiuju Dai, Yoichi Mizukami, Kenji Watanabe, Teruko Tsuda, Mutsumi Shidahara, Satoshi Yoshida, Kazuki Yatsuzuka, Ken Shiraishi, Hideki Mori, Masamoto Murakami, et al. Trehalose prevents IL-4/IL-13-induced skin barrier impairment by suppressing IL-33 expression and increasing Nrf2 activation in human keratinocytes in vitro. The Journal of investigative dermatology. 2024
Kazuki Yatsuzuka, Takuya Matsumoto, Teruki Kidani, Yasuhiro Fujisawa, Masamoto Murakami. Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab. Cureus. 2024
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui. Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. American Journal of Clinical Dermatology. 2024